A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 800,834 shares of ABT stock, worth $92.8 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
800,834
Previous 814,240 1.65%
Holding current value
$92.8 Million
Previous $84.6 Million 7.91%
% of portfolio
0.12%
Previous 0.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$100.07 - $118.13 $1.34 Million - $1.58 Million
-13,406 Reduced 1.65%
800,834 $91.3 Million
Q2 2024

Jul 19, 2024

SELL
$100.73 - $112.44 $1.37 Million - $1.53 Million
-13,584 Reduced 1.64%
814,240 $84.6 Million
Q1 2024

Apr 22, 2024

BUY
$109.52 - $120.96 $1.03 Million - $1.13 Million
9,365 Added 1.14%
827,824 $94.1 Million
Q4 2023

Jan 16, 2024

SELL
$90.19 - $110.4 $127,258 - $155,774
-1,411 Reduced 0.17%
818,459 $90.1 Million
Q3 2023

Oct 24, 2023

SELL
$95.53 - $114.62 $1.31 Million - $1.57 Million
-13,704 Reduced 1.64%
819,870 $79.4 Million
Q2 2023

Jul 25, 2023

SELL
$100.78 - $112.29 $1.09 Million - $1.22 Million
-10,831 Reduced 1.28%
833,574 $90.9 Million
Q1 2023

Apr 14, 2023

BUY
$96.86 - $114.01 $2 Million - $2.35 Million
20,631 Added 2.5%
844,405 $85.5 Million
Q4 2022

Feb 08, 2023

SELL
$95.06 - $111.52 $2.53 Million - $2.97 Million
-26,633 Reduced 3.13%
823,774 $90.5 Million
Q3 2022

Oct 25, 2022

SELL
$96.76 - $112.03 $350,077 - $405,324
-3,618 Reduced 0.42%
850,407 $82.3 Million
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $2.97 Million - $3.59 Million
29,077 Added 3.52%
854,025 $92.8 Million
Q1 2022

May 11, 2022

SELL
$114.02 - $139.04 $2.89 Million - $3.52 Million
-25,334 Reduced 2.98%
824,948 $97.6 Million
Q4 2021

Feb 08, 2022

SELL
$115.53 - $141.46 $3.81 Million - $4.66 Million
-32,967 Reduced 3.73%
850,282 $120 Million
Q3 2021

Nov 02, 2021

BUY
$116.66 - $129.06 $5.33 Million - $5.9 Million
45,720 Added 5.46%
883,249 $104 Million
Q2 2021

Aug 11, 2021

BUY
$105.79 - $124.53 $4.22 Million - $4.96 Million
39,867 Added 5.0%
837,529 $97.1 Million
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $6.36 Million - $7.5 Million
58,475 Added 7.91%
797,662 $95.6 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $3.75 Million - $4.09 Million
35,730 Added 5.08%
739,187 $80.9 Million
Q3 2020

Nov 04, 2020

SELL
$91.64 - $111.29 $2.07 Million - $2.52 Million
-22,621 Reduced 3.12%
703,457 $76.6 Million
Q2 2020

Jul 17, 2020

SELL
$76.57 - $98.0 $540,660 - $691,978
-7,061 Reduced 0.96%
726,078 $66.4 Million
Q1 2020

Apr 21, 2020

BUY
$62.82 - $91.86 $6.81 Million - $9.96 Million
108,428 Added 17.36%
733,139 $57.9 Million
Q4 2019

Feb 12, 2020

BUY
$78.51 - $87.4 $1.69 Million - $1.88 Million
21,554 Added 3.57%
624,711 $54.3 Million
Q3 2019

Nov 07, 2019

BUY
$81.84 - $88.74 $1.54 Million - $1.67 Million
18,832 Added 3.22%
603,157 $50.5 Million
Q2 2019

Aug 06, 2019

BUY
$72.88 - $85.0 $2.1 Million - $2.45 Million
28,865 Added 5.2%
584,325 $49.1 Million
Q1 2019

May 06, 2019

BUY
$66.22 - $80.06 $212,235 - $256,592
3,205 Added 0.58%
555,460 $44.4 Million
Q4 2018

Feb 11, 2019

BUY
$65.56 - $74.27 $2.56 Million - $2.9 Million
39,077 Added 7.61%
552,255 $39.9 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $4.49 Million - $5.42 Million
73,912 Added 16.83%
513,178 $37.6 Million
Q2 2018

Jul 30, 2018

BUY
$57.57 - $63.54 $407,192 - $449,418
7,073 Added 1.64%
439,266 $26.8 Million
Q1 2018

Apr 16, 2018

BUY
$56.27 - $63.62 $670,682 - $758,286
11,919 Added 2.84%
432,193 $25.9 Million
Q4 2017

Feb 09, 2018

SELL
$53.68 - $57.47 $226,583 - $242,580
-4,221 Reduced 0.99%
420,274 $24 Million
Q3 2017

Oct 26, 2017

BUY
$48.06 - $53.64 $516,356 - $576,308
10,744 Added 2.6%
424,495 $22.7 Million
Q2 2017

Aug 15, 2017

BUY
N/A
413,751
413,751 $20.1 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.